Physician perspectives on non-steroidal anti-inflammatory drugs: a comprehensive survey on usage and preferences

Ajitkumar Gondane; Dattatray Pawar

doi:10.18203/2319-2003.ijbcp20242431

Authors

Ajitkumar Gondane Medical Affairs Division, Alkem Laboratories, Alkem House, Lower Parel, Mumbai, Maharashtra, India
Dattatray Pawar Medical Affairs Division, Alkem Laboratories, Alkem House, Lower Parel, Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20242431

Keywords:

NSAID utilization, Acute painful conditions, Physician preferences, Nimesulide safety

Abstract

Background: Physician’s choices of NSAIDs are shaped by efficacy, safety, patient factors, and clinical context, impacting policies and patient outcomes. This survey aimed to explore NSAID use in acute painful conditions, focusing on healthcare professionals' preferences.

Methods: A descriptive, questionnaire-based, cross-sectional study was conducted among 1,028 physicians at APICON-2024.

Results: The survey found that 57.4% of respondents were consultants and 33.4% were general physicians. Most practiced independently (55.6%) or in hospitals (35.5% in government and 7.9% in corporate hospitals). Over 75% frequently prescribed NSAIDs, with diclofenac being the most common (54.8%). NSAIDs were typically prescribed for one week (72.6%) and used mainly for low back pain (77.5%), joint pain, migraine, and post-surgical pain. Safety concerns included gastrointestinal (72.4%), renal (59.3%), and hepatic issues. Over 68% viewed nimesulide as safer for the gastrointestinal and renal systems than other NSAIDs, though opinions varied. More than 90% of physicians also prescribed NSAIDs with paracetamol.

Conclusions: The survey offers insights into NSAID use among Indian physicians, with frequent use for pain management, especially for low back and joint pain. Diclofenac is the most prescribed, with a typical duration of one week. Safety concerns remain significant, particularly regarding nimesulide. The findings highlight diverse practices and ongoing safety considerations in NSAID use.

Metrics

Metrics Loading ...

References

Ghlichloo I, Gerriets V. Nonsteroidal anti-inflammatory drugs (NSAIDs). Treasure Island (FL). StatPearls Publishing. 2024. Available at: www.ncbi.nlm.nih.gov.

Lin JY, Zhang Y, Bian Y, Zhang YX, Du RZ, Li M, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) in the environment: Recent updates on the occurrence, fate, hazards and removal technologies. Sci Tot Environ. 2023;16:68-97.

Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochemical pharmacology. 2020;180:114147.

Sohail R, Mathew M, Patel KK, Reddy SA, Haider Z, Naria M, et al. Effects of non-steroidal anti-inflammatory drugs (NSAIDs) and gastroprotective NSAIDs on the gastrointestinal tract: a narrative review. Cureus. 2023;15(4).

Katz N. The impact of pain management on quality of life. J pain sym Mang. 2002;24(1):38-47.

Miller LG, Prichard JG. Selecting nonsteroidal anti-inflammatory drugs: pharmacologic and clinical considerations. JABFP. 1989;2(4):257-71.

Paul AD, Chauhan CK. Study of usage pattern of nonsteroidal anti-inflammatory drugs (NSAIDs) among different practice categories in Indian clinical setting. Euro J Clin Pharmacol. 2005;60:889-92.

Zeinali M, Tabeshpour J, Maziar SV, Taherzadeh Z, Zirak MR, Sent D, et al. Prescription pattern analysis of nonsteroidal anti-inflammatory drugs in the northeastern iranian population. J Res Pharm Prac. 2017;6(4):206-10.

Mäntyselkä P, Kumpusalo E, Takala J, Ahonen R. Variability in prescribing for musculoskeletal pain in Finnish primary health care. Pharmacy World and Science. 2001;23:232-6.

Al-Azayzih A, Al-Azzam SI, Alzoubi KH, Jarab AS, Kharaba Z, Al-Rifai RH, Alnajjar MS. Nonsteroidal anti-inflammatory drugs utilization patterns and risk of adverse events due to drug-drug interactions among elderly patients: a study from Jordan. J Saudi Pharma. 2020;28(4):504-8.

Motgahre VM, Bajait CS, Turankar A, Pimpalkhute SA, Dholpure M. Prescription pattern and adverse drug reaction profile of drugs prescribed with focus on NSAIDs for orthopedic indications at a tertiary care hospital. Skin. Skin. 2016;1:6.

Alam N, Bhardwaj A, Tiwari R, Sharma S, Dabas V. Drug utilization pattern of patients using NSAIDs in South Delhi hospital. Int J Pharm Sci. 2012;4(3):703-7.

Farheen H, Subhani G, Mohsin M. Prescription pattern of non-steroidal anti-inflammatory drugs in patients with acute musculoskeletal pain. Int J Basic Clin Pharmacol. 2016;5(6):2504-9.

Anandan I, Selvaraj N, Anandabaskar N, Meenakshi R, Dhamodharan A, Ganesan S, et al. Assessment of drug use pattern of nonsteroidal anti-inflammatory drugs using the World Health Organization core indicators in a tertiary care teaching hospital A cross-sectional study. Nation J Physio Pharm. 2019;9(10):1021-6.

Neupane GP, Rai M, Rokaya PK. Patterns of prescription and adverse drug reaction profile of non-steroidal anti-inflammatory drugs at orthopedic out-patients department. Nep Med Col J. 2022;24(2):170-5.

Levy DM, Imundo LF. Nonsteroidal anti-inflammatory drugs: a survey of practices and concerns of pediatric medical and surgical specialists and a summary of available safety data. Pediatric Rheumatol. 2010;8:1-8.

McDonald J, McBain L, Dowell AC, Morris C. GPs’ views and experiences of prescribing non-steroidal anti-inflammatory drugs: a qualitative study. BJGP open. 2017;1:2.

Schjøtt J, Erdal H, Opskar S, Bjånes TK. Perception of prescribing factors and purchase statistics of non-steroidal anti-inflammatory drugs in an orthopedic clinic. BMC Research Notes. 2020;13:1-6.

Crichton B, Green M. GP and patient perspectives on treatment with non-steroidal anti-inflammatory drugs for the treatment of pain in osteoarthritis. Current Medical Research and Opinion. 2002;18(2):92-6.

Rainsford KD. Relationship of nimesulide safety to its pharmacokinetics: assessment of adverse reactions. Rheumatology. 1999;38(1):4-10.

Patil S, Nadaf N, Gupta S, Barai P, Makhija S, Lodha P, et al. A comparative analysis of the efficacy and safety of nimesulide/paracetamol fixed-dose combination with other NSAIDS in acute pain management: a randomized, prospective, multicenter, active-controlled study (the SAFE-2 study). Cureus. 2024;16:4.